Figure 3
Drug sensitivity across a panel of CREB3L1-deficient luminal A and TNBC cell lines. Cell viability was measured after 4Â days of drug treatment over a range of drug concentrations as before. EC50 values were determined as per Table 2 and plotted here for comparison.
